Paulus Stoffels

Four sales make up the core of Paulus Stoffels' record, at Johnson & Johnson: EUR 41,853,288 in total, with a median of EUR 11,616,722. The three largest are dated February 15, 2018 (EUR 16,180,532), July 24, 2017 (EUR 11,747,201) and February 17, 2016 (EUR 11,486,244). No purchase is recorded.

The 38 filings, published between January 20, 2016 and July 6, 2026, come almost entirely from Johnson & Johnson (37, as Exec VP, Chief Scientific Off). The other concerns Takeda Pharmaceutical Co Ltd, where the listed title is Director. They break down into 18 share grants and 16 option exercises, alongside the four sales.

By year: 7 filings in 2016, 10 in 2017, 7 in 2018, 5 in 2019, 4 in 2020 and one in 2026. The median publication delay is 4 days. One filing falls in the last twelve months, with neither a sale nor a purchase.

Stoffels has 1, 1 and 1 own market trades within 30 days of colleagues at Johnson & Johnson, in that order. All of them in the same direction. Colleagues in order: Dominic J. Caruso, Gary J. Pruden and Joaquin Duato.